Health Catalyst
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Health Catalyst generated cash of -$33,080,000, which is more than the previous year. Cash used in financing activities reached the amount of $2,730,000 last year. Net change in cash is therefore -$10,036,000.
Cash Flow
| 2017 | -36.82M | 22.40M | 24.87M |
|---|---|---|---|
| 2018 | -40.29M | 21.40M | 24.34M |
| 2019 | -32.18M | -209.60M | 231.38M |
| 2020 | -26.14M | -82.56M | 182.60M |
| 2021 | -23.12M | -139.67M | 264.08M |
| 2022 | -35.27M | -39.02M | -2.61M |
| 2023 | -33.08M | 20.29M | 2.73M |
HCAT Cash Flow Statement (2017 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|
Cash at beginning of period | 116.31M | 193.22M | 91.95M | 18.03M | 28.43M | 22.97M | 12.52M |
Operating activities | |||||||
Net income | -118.14M | -137.40M | -153.21M | -115.01M | -60.09M | -61.98M | -47.03M |
| Adjustments to reconcile net income to cash generated by operating activities: | |||||||
Depreciation and amortization | 42.22M | 48.29M | 37.52M | 18.72M | 9.21M | 7.41M | 5.89M |
Stock-based compensation expense | 55.75M | 72.10M | 65.14M | 37.95M | 17.84M | 0 | 4.24M |
| Deferred income tax benefit | 55.75M | 72.10M | 65.14M | 37.95M | 17.84M | 0 | 4.24M |
| Changes in operating assets and liabilities: | |||||||
Accounts receivable, net | -13.66M | 788K | 102K | -16.44M | 127K | -3.62M | 4.44M |
Inventories | 0 | 0 | -8.32M | -7.08M | -3.65M | 2.46M | -2.55M |
Accounts payable | 4.86M | -4.70M | 5.20M | 8.24M | -86K | 4.42M | -6.28M |
Cash generated by operating activities | -33.08M | -35.27M | -23.12M | -26.14M | -32.18M | -40.29M | -36.82M |
Investing activities | |||||||
Purchases Of Investments | -290.83M | -308.96M | -261.36M | -189.52M | -256.00M | -13.99M | -46.42M |
Investments In Property Plant And Equipment | -1.23M | -17.41M | -18.46M | -10.46M | -4.33M | -2.50M | -3.34M |
Acquisitions Net | -11.39M | -27.84M | -46.76M | -101.65M | 1.93M | 228K | 878K |
Cash generated by investing activities | 20.29M | -39.02M | -139.67M | -82.56M | -209.60M | 21.40M | 22.40M |
Financing activities | |||||||
Common Stock Issued | 0 | 0 | 245.18M | 40.53M | 194.64M | 0 | 23.86M |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | -1.80M | -8.39M | 0 | 0 | 0 | -8.71M | 0 |
Repayments of term debt | 0 | 0 | 0 | -57.04M | 25.34M | 0 | 9.78M |
Cash used in financing activities | 2.73M | -2.61M | 264.08M | 182.60M | 231.38M | 24.34M | 24.87M |
Net Change In Cash | -10.03M | -76.91M | 101.27M | 73.92M | -10.39M | 5.45M | 10.45M |
Cash at end of period | 106.27M | 116.31M | 193.22M | 91.95M | 18.03M | 28.43M | 22.97M |
| Data source | Data source | Data source | Data source | Data source |